Sell:$0.59Buy:$0.67$0.05 (8.89%)
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
15 May 2024 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIPPrivate Equity | Sell Option/Award related | 24,344 | $0.38 | $9,279.93 | 13,773,653 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 40,350 | $231.10 | $9,324,885.00 | 53,840 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 40,350 | $231.10 | $9,324,885.00 | 53,840 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 13,490 | $231.10 | $3,117,539.00 | 13,490 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 13,490 | $231.10 | $3,117,539.00 | 13,490 |
15 March 2024 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIPPrivate Equity | Buy Regular purchase transaction | 4,327 | $231.10 | $999,969.70 | 4,327 |
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 40,350 | $231.10 | $9,324,885.00 | 53,840 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 40,350 | $231.10 | $9,324,885.00 | 53,840 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 13,490 | $231.10 | $3,117,539.00 | 13,490 |
15 March 2024 | DEERFIELD MANAGEMENT CO LPPrivate Equity | Buy Regular purchase transaction | 13,490 | $231.10 | $3,117,539.00 | 13,490 |
15 March 2024 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIPPrivate Equity | Buy Regular purchase transaction | 4,327 | $231.10 | $999,969.70 | 4,327 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.